Tovetumab
Monoclonal antibody / From Wikipedia, the free encyclopedia
Tovetumab is an anti-PDGFRa monoclonal antibody designed for the treatment of cancer.[1] It was developed by MedImmune, and trialed for use in glioblastoma and non-small cell lung cancer.[2] Development was discontinued in 2013.[3][4]
Quick Facts Monoclonal antibody, Type ...
Monoclonal antibody | |
---|---|
Type | ? |
Source | Human |
Target | PDGFRA |
Clinical data | |
ATC code |
|
Identifiers | |
CAS Number | |
ChemSpider |
|
UNII | |
KEGG | |
Chemical and physical data | |
Formula | C6400H9906N1726O2002S54 |
Molar mass | 144792.97 g·mol−1 |
Close
This drug was developed by MedImmune, LLC.[citation needed]